Dr Joel Bernstein to remain at Winston Pharmaceuticals
This article was originally published in Scrip
Winston Pharmaceuticals (US) has announced that Dr Joel Bernstein, founder of the company's wholly owned subsidiary Winston Laboratories, has rescinded his resignation as president and chief executive officer and will now continue to serve in the positions for the duration of the term set forth in his employment agreement. Dr Jeffrey Bernstein, who had previously been announced by the company's board of directors as a successor to Dr Joel Bernstein effective September 22nd (scripnews.com, July 30th, 2009), has withdrawn as a candidate for the positions. Winston's board reconfirmed that Robert Yolles, a member of the company's board since 2008, will succeed Dr Joel Bernstein as chairman on September 22nd.